These findings collectively highlight the dual role of STAT3 in neuroinflammatory processes and neuroendocrine regulation, underscoring its significance as a molecular target in the pathophysiology and potential therapeutic intervention of MDD. The gene discussed is STAT3; the disease is major depressive disorder.